Timoma Dokter Terbaik di Turquia - TOP-29 dokter

Dr. Mustafa Solak berspesialisasi dalam kasus timoma dengan pelatihan fellowship di Institut Kanker Universitas Hacettepe.

• Menangani kasus kompleks kanker payudara, paru-paru, dan saluran pencernaan
• Menyelesaikan pelatihan di The University of Texas MD Anderson Cancer Center
• Berpengalaman dalam mendiagnosis dan mengobati berbagai jenis kanker

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Profesor Onkologi Medis dengan pengalaman luas dalam onkologi gastrointestinal – Prof. Sağlam mengepalai Departemen Onkologi Medis di Rumah Sakit Gayrettepe Florence Nightingale.

• Spesialisasi dalam timoma dan tumor neuroendokrin
• Anggota ESMO, ASCO, dan ENET
• Menyelesaikan pendidikan di Universitas Istanbul – salah satu sekolah kedokteran ternama di Turki

Professor Doctor Sefik Igdem berspesialisasi dalam onkologi radiasi, dengan pengalaman luas dalam kanker kepala dan leher di Rumah Sakit Gayrettepe Florence Nightingale.

• Lebih dari 25 tahun pengalaman dalam onkologi radiasi
• Ahli dalam perawatan konformal dan teknologi canggih seperti Truebeam Stx
• Profesor di Universitas T.R. Demiroğlu Bilim – membimbing spesialis masa depan
• Berspesialisasi dalam kasus-kasus kompleks yang memerlukan terapi radiasi presisi

Spesialisasi dalam terapi target dan imunoterapi untuk timoma – Assoc. Prof. Mutlu menempuh pendidikan di Universitas Akdeniz dan di Amerika Serikat.

• Lebih dari 20 tahun pengalaman dalam onkologi medis
• Ahli dalam penelitian genetik generasi terbaru untuk pengobatan kanker
• Bpraktik di Kompleks Rumah Sakit Medical Park Antalya
• Fokus pada pendekatan pengobatan komplementer di samping perawatan konvensional

Assoc. Dr. Abdullah Sakin memimpin Departemen Onkologi Medis di Rumah Sakit Medipol Bahçelievler, yang berspesialisasi dalam pengobatan timoma.

• Kepala Onkologi Medis di Fakultas Kedokteran Universitas Yüzüncü Yıl
• Pelatihan Onkologi Medis di İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi
• Pengalaman dalam penyakit dalam dan onkologi sejak 2012
• Bekerja di Rumah Sakit Medipol Bahçelievler, fasilitas layanan kesehatan terkemuka

Spesialis Dr. Rahib Hasanov membawa keahlian onkologi internasional dari pelatihan di Houston Methodist Hospital dan Universitas Marmara.

• Menyelesaikan spesialisasi Onkologi Medis dengan fokus pada pengobatan modern
• Menggabungkan imunoterapi dan terapi target ke dalam perawatan pasien
• Berdiskusi dalam perawatan onkologi yang dipersonalisasi untuk berbagai kebutuhan pasien
• Menangani pasien internasional dari Eropa dan Timur Tengah secara rutin

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Profesor Onkologi Medis sejak 2016 – Dr. Sezer Saglam bekerja di departemen onkologi Rumah Sakit Florence Nightingale Istanbul.

• Spesialisasi dalam tumor gastrointestinal dan neuroendokrin
• Anggota asosiasi onkologi utama termasuk ESMO dan ASCO
• Lebih dari 20 tahun pengalaman menangani kasus onkologi toraks

Dr. Tahsin Ozadli berspesialisasi dalam timoma dan kanker toraks lainnya di Rumah Sakit Valued Med Hub, dengan pelatihan ekstensif dalam onkologi medis.

• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk Meram
• Mengambil spesialisasi onkologi medis di Rumah Sakit Pelatihan dan Penelitian Onkologi Ankara
• Berpengalaman dalam mengobati kanker paru-paru, esofagus, dan lambung
• Aktif dalam penelitian dengan publikasi di bidang onkologi

Dr. Yildiz berspesialisasi dalam timoma dan tumor neuroendokrin, dengan penelitian ekstensif yang dipublikasikan di jurnal medis internasional.

• Menerbitkan 17+ studi tentang kondisi onkologi langka
• Keahlian dalam mendiagnosis dan mengobati kasus timoma yang kompleks
• Bekerja di Rumah Sakit Universitas Medipol Mega – pusat onkologi terkemuka

Profesor Ondzhel berspesialisasi dalam bedah onkologi dengan fokus pada kanker kolorektal dan rektum, melakukan prosedur kompleks di Rumah Sakit Universitas Medipol Mega.

• Menjalani pelatihan di Cleveland Clinic – pemimpin dalam bedah kolorektal
• Proktologis bersertifikat Komisi Eropa dengan pengalaman lebih dari 25 tahun
• Riset yang dipublikasikan tentang adenokarsinoma rektum dan reseksi kanker multiviskeral
• Kepala Departemen Bedah di Universitas Medipol Istanbul
• Anggota pendiri Eurasian Colorectal Technologies Association

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Prof. Madya Nail Paksoy membawa keahlian dari Institut Onkologi Universitas Istanbul dan Rumah Sakit Medipol Bahçelievler, dengan fokus pada timoma dan keganasan toraks lainnya.

• Tersertifikasi Dewan ESMO dalam Onkologi Medis sejak 2022
• Menulis penelitian tentang kanker toraks langka yang diterbitkan dalam jurnal internasional
• Berpartisipasi dalam 8 uji klinis internasional untuk terapi kanker terbaru
• Spesialisasi dalam imunoterapi dan pendekatan terapi target

Dr. Alemdar berspesialisasi dalam pengobatan timoma dengan pengalaman luas di bidang onkologi medis di rumah sakit terkemuka di Turki.

• Menempuh pendidikan di Universitas Akdeniz – lembaga medis terkemuka di Turki
• Berpengalaman lebih dari 15 tahun di bidang onkologi dan penyakit dalam
• Bekerja di Medical Park Antalya Hospital Complex – dilengkapi dengan fasilitas perawatan kanker yang canggih
• Anggota Asosiasi Onkologi Medis Turki

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.